Minnesota Diabetics

Join the American Diabetes Association for our Minnesota DiabetesAdvocacy Day at the Capitol on March 5th? It’s not too late to register atdiabetes.org/mndiabetesday.

Attendees will learn about three bills that will help Minnesotans living with diabetes, and then meet with their legislators in small groups.

  • S.F. 366 would require companies to justify and explain price increases of insulin and other diabetes medications, ensuring price transparency in the supply chain and help Minnesotans struggling to afford theskyrocketing price of insulin and other drugs.
  • S.F. 365 would prohibit insurance companies from removing coverage of a particular brand of insulin or equipment and supplies during a customer’s contract year, creating transparency and protecting people with diabetes from mid-year non-medical switching.
  • H.F. 365 would repeal discriminatory driver licensing requirements for people with diabetes.

Come learn about how these important bills will improve the lives of those living with diabetes and meet with your elected officials and continue the fight for positive changes in Minnesota policy!

This event is free to attend. Don’t miss this unique opportunity!

WHEN: Tuesday, March 5th, 9:00 a.m. - 3:00 p.m.
WHERE: Minnesota State Office Building, 100 Rev Dr. Martin Luther King Jr. Boulevard, St. Paul, MN 55155, Room #400S


Some exciting news coming from the capitol: four insulin bills are being heard in committee on TUESDAY , the afternoon of our advocacy training (the highlighted ones below are the bills the ADA is advocating for at our diabetes day). All info is below, and I encourage you to attend committee and testify, if you’re willing and able (and it doesn’t conflict with a pre-scheduled meeting).

More information is below:

Four insulin bills are having hearings in the House on Tuesday – 2:30pm in the House Commerce Committee!

Chair: Rep. Laurie Halverson

Location: Basement Hearing Room, 2:30pm

Agenda: Bills may be taken in any order.

HF 485 (Howard) Insulin assistance program established, insulin assistance account established in the special revenue fund, drug manufacturers required to pay an insulin product fee, emergency refills provided, and money appropriated.

HF 289 (Mann) Diabetes prescription drugs cost reporting required.

HF 288 (Masin) Health plan companies prohibited from removing coverage of insulin or equipment and supplies during an enrollee’s contract year.

HF 284 (Halverson) Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

If you want to testify, please contact:

rep.michael.howard@house.mn for the insulin pricing transparency bill (HF289)

Anna.Fineanganofo@house.mn for non-medical switching (HF288)

Christine N. Fallabel, MPH

Director, State Government Affairs and Advocacy

(CO, WY, KS, OK, MN, ND, SD, IA, NE)